Table 3 Positive-NSN rates in multivariate analysis for patients with completion ALND and radiotherapy.

From: Sentinel node involvement with or without completion axillary lymph node dissection: treatment and pathologic results of randomized SERC trial

 

Odds ratio

95% CI

P value

AC

   

No

1

  

AC after ALND

2.99

1.70–5.24

<0.0001

AC before ALND

1.51

0.77–2.98

0.2318

Tumor size

   

≤10

1

  

10–30

1.92

0.86–4.32

0.1124

>30

1.26

0.46–3.43

0.6547

LVI

   

No

1

  

Yes

0.80

0.52–1.23

0.2992

Grade SBR

   

1

1

  

2

1.21

0.66–2.19

0.5376

3

0.89

0.45–1.79

0.7480

Nb positive SN

   

≤2

1

  

>2

3.45

1.21–9.85

0.0209

Extracapsular extension

   

No

1

  

Yes

1.21

0.75–1.94

0.4346

SN status

   

ITC

1

  

Micro-metastases

1.62

0.35–7.59

0.5370

Macro-metastases

3.70

0.84–6.33

0.0842

  1. LVI lympo-vacular invasion, SN sentinel node, AC adjuvant chemotherapy.
  2. Bold entries indicate statistical significant differences.
Back to article page